Skip to main content
Premium Trial:

Request an Annual Quote

GenomeWeb Top 40 Down 5 Percent in June, Tracking Broader Market Decline

Stock Market

NEW YORK – Stocks of molecular diagnostics and omics companies were down in June, largely tracking the general market.

Overall, the GenomeWeb Top 40 was down 5 percent. In comparison, the Dow Jones Industrial Average was down 7 percent from May, while the Nasdaq was down 9 percent. Bucking this broader trend was the Nasdaq Biotech Index, which was up 1 percent. Of the 40 firms tracked by GenomeWeb, 29 saw their stock prices drop month over month, and 11 saw shares increase in value.

Chinese precision oncology firm Biotech Burning Rock, which posted the largest decline of any GenomeWeb Top 40 firm in May, saw the largest gain in June, up 21 percent month over month. At the end of May, the company reported that its Q1 2022 revenues were up 27 percent year over year and reiterated its full-year 2022 revenue guidance of approximately RMB 620 million, implying 22 percent growth over full-year 2021.

Burning Rock also announced at the beginning of June that it received CE marking for its OverC Multi-Cancer Detection Blood Test, which is intended for the early detection and localization of multiple cancer types in individuals 40 to 75 years of age.

Diagnostics firm Veracyte was June's second biggest gainer, up 13 percent month over month. There were no specific developments that appeared to drive the jump, though perhaps investors saw a buying opportunity in early June when Veracyte’s stock hit its lowest level since the end of 2018.

Diagnostics outfit Meridian Bioscience was the third biggest gainer in June, up 11 percent. The month continued a year of steady increases for the company, which is up almost 50 percent since the start of the year. In June it introduced its Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix for molecular detection of nucleic acid from crude fecal specimens.

Proteomics company Quantum-Si saw the biggest decline in June, down 45 percent month over month. The company is planning to launch its proteomics platform in the second half of the year but has yet to generate any revenue.

Cue Health was down 40 percent month over month as demand dried up for its COVID-19 test offerings. The company confirmed this week that it will be laying off 170 people "due to the economic challenges that are impacting many industries" and the lack of funding for COVID-19 testing from the US government.

Genetic testing firm Invitae was down 34 percent month over month, continuing a decline that has seen the company's stock price fall by 72 percent since the beginning of April. The company did not report any news appearing to drive the June drop.

GenomeWeb Top 40        
Company Ticker 30-Jun-22 31-May-22 % change
Adaptive Biotechnologies ADPT 8.09 7.82 3.45
Agilent Technologies A 118.77 127.56 -6.89
Becton Dickinson* BDX 246.53 255.80 -3.62
Berkeley Lights BLI 4.97 4.78 3.97
Bio-Rad Laboratories BIO 495.00 537.79 -7.96
Bio-Techne TECH 364.64 369.73 -1.38
Bruker BRKR 62.76 62.48 0.45
Burning Rock Biotech BNR 2.91 2.40 21.25
CareDx CDNA 21.48 25.15 -14.59
Castle Biosciences CSTL 21.95 22.27 -1.44
Cue Health HLTH 3.20 5.29 -39.51
Danaher** DHR 253.52 263.82 -3.90
Exact Sciences EXAS 39.39 49.81 -20.92
Fulgent Genetics FLGT 54.33 54.51 -0.33
Ginkgo Bioworks DNA 2.38 3.08 -22.73
Guardant Health GH 40.34 40.98 -1.56
Hologic HOLX 69.30 75.27 -7.93
Illumina ILMN 184.36 239.48 -23.02
Invitae NVTA 2.44 3.67 -33.51
Meridian Bioscience VIVO 30.42 27.50 10.62
Myriad Genetics MYGN 18.17 19.24 -5.56
NanoString Technologies NSTG 12.70 15.64 -18.80
Natera NTRA 35.44 36.69 -3.41
NeoGenomics Laboratories NEO 8.15 8.42 -3.21
Pacific Biosciences PACB 4.42 5.63 -21.49
Personalis PSNL 3.45 3.96 -12.88
PerkinElmer PKI 142.22 149.67 -4.98
Qiagen QGEN 47.20 45.95 2.72
Quanterix QTRX 16.19 16.86 -3.97
Quantum-SI QSI 2.32 4.25 -45.41
Quidel QDEL 97.18 95.03 2.26
Seer SEER 8.95 8.88 0.79
SomaLogic SLGC 4.52 6.00 -24.67
Sophia Genetics SOPH 3.62 4.20 -13.81
Thermo Fisher Scientific TMO 543.28 567.57 -4.28
Twist Bioscience TWST 34.96 34.04 2.70
Veracyte VCYT 19.90 17.58 13.20
Waters WAT 330.98 327.95 0.92
23andMe ME 2.48 3.00 -17.33
10x Genomics TXG 45.25 51.19 -11.60
GenomeWeb Top 40 Average   85.20 90.02 -5.35
*Becton Dickinson paid a dividend of $.87 on June 8        
**Danaher paid a dividend of $.25 on June 23        
***Thermo Fisher Scientific paid a dividend of $.30 on June 14        


The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.